OmniAb, Inc. (NASDAQ:OABI) CFO Kurt A. Gustafson Sells 7,255 Shares

OmniAb, Inc. (NASDAQ:OABI) CFO Kurt A. Gustafson sold 7,255 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $3.67, for a total value of $26,625.85. Following the transaction, the chief financial officer now owns 206,211 shares of the company’s stock, valued at $756,794.37. The trade was a 3.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

OmniAb Price Performance

Shares of OABI traded up $0.01 during midday trading on Wednesday, hitting $3.67. 294,723 shares of the company traded hands, compared to its average volume of 489,354. OmniAb, Inc. has a one year low of $3.10 and a one year high of $6.55. The firm has a market cap of $518.28 million, a P/E ratio of -5.92 and a beta of -0.12. The stock has a 50-day moving average of $3.49 and a 200-day moving average of $3.91.

Analyst Ratings Changes

Several equities research analysts have commented on OABI shares. Benchmark reaffirmed a “buy” rating and set a $8.00 price objective on shares of OmniAb in a report on Thursday, November 14th. HC Wainwright reaffirmed a “buy” rating and issued a $11.00 price objective on shares of OmniAb in a report on Thursday, November 14th.

Hedge Funds Weigh In On OmniAb

Several hedge funds have recently bought and sold shares of OABI. Palumbo Wealth Management LLC grew its position in shares of OmniAb by 12.5% during the 3rd quarter. Palumbo Wealth Management LLC now owns 24,640 shares of the company’s stock valued at $104,000 after purchasing an additional 2,744 shares in the last quarter. Invesco Ltd. boosted its stake in OmniAb by 3.3% during the fourth quarter. Invesco Ltd. now owns 93,653 shares of the company’s stock valued at $332,000 after buying an additional 2,997 shares during the period. Connors Investor Services Inc. grew its position in OmniAb by 18.4% during the fourth quarter. Connors Investor Services Inc. now owns 29,611 shares of the company’s stock worth $105,000 after buying an additional 4,611 shares in the last quarter. SG Americas Securities LLC increased its stake in OmniAb by 16.5% in the 4th quarter. SG Americas Securities LLC now owns 40,609 shares of the company’s stock worth $144,000 after acquiring an additional 5,751 shares during the last quarter. Finally, Sherbrooke Park Advisers LLC raised its holdings in shares of OmniAb by 53.5% in the 4th quarter. Sherbrooke Park Advisers LLC now owns 17,226 shares of the company’s stock valued at $61,000 after acquiring an additional 6,001 shares in the last quarter. Hedge funds and other institutional investors own 72.08% of the company’s stock.

About OmniAb

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.